Asset Managers Tech analyzes & addresses the policy and advocacy interests of the investment management industry in this COVID – 19 period. As a not for profit trade group, we focus particular attention on the use of modern technology by AMT members along with other industry leaders.
By Dr. Stanley Zaborowski, AMT Medical Adviser:
Regarding the Johnson & Johnson COVID – 19 Vaccine – There should be a pause in offering J & J vaccine for 10 to 14 days. Then the FDA and the CDC can make a decision upon considering the risk of blood clots apparently involving one recipient for each batch of 1,000,000 doses of J & J administered. If the Government ends up pulling back on use of J & J, it is important to note that the U.S. would still be able to achieve “herd immunity” (to the level of 75 to 85% of American residents) based on available supply of the Pfizer and Moderna vaccines.
By Xavier Touret, AMT Industry Practices Adviser:
Regarding Working From Home during the Pandemic – Because WFH has involved extensive reliance on personal technology devices, AMT should consider studying the effects of devices on firms’ corporate internet networks. Other questions for AMT study: what is the effect on a firm’s software resources with the increased use of personal devices & what are the standards during WFH for keeping an inventory of your organization’s IT infrastructure?
AMT welcomes industry input regarding the above noteworthy points developed by our speakers at our 4/15 Zoom meeting. Please CLICK HERE to view a video replay of this meeting. Kindly contact Joe Sack with questions or comments regarding these newly issued noteworthy points.
Joe Sack, President, Asset Managers Tech